Effects of extracellular pH and hypoxia on the function and development of antigen-specific cytotoxic T lymphocytes
Open accessAbstract
The major effector cells for cellular adaptive immunity are CD8(+) cytotoxic T lymphocytes (CTLs), which can recognize and kill virus-infected cells and tumor cells. Although CTLs exhibit strong cytolytic activity against target cells in vitro, a number of studies have demonstrated that their function is often impaired within tumors. Nevertheless, CTLs can regain their cytotoxic ability after escaping from the tumor environment, suggesting that the milieu created by tumors may affect the function of CTLs. As for the tumor environment, the patho-physiological situation present in vivo has been shown to differ from in vitro experimental conditions. In particular, low pH and hypoxia are the most important microenvironmental factors within growing tumors. In the present study, to determine the effect of these factors on CTL function in vivo, we examined the cytolytic activity of CTLs against their targets using murine CTL lines and the induction of these cells from memory cells under low pH or hypoxic conditions using antigen-primed spleen cells. The results indicated that both cytotoxic activity and the induction of functional CTLs were markedly inhibited under low pH. In contrast, in hypoxic conditions, although cytotoxic activity was almost unchanged, the induction of CTLs in vitro showed a slight enhancement, which was completely abrogated in low pH conditions. Therefore, antigen-specific CTL functions may be more vulnerable to low pH than to the oxygen concentration in vivo. The findings shown here provide new therapeutic approaches for controlling tumor growth by retaining CTL cytotoxicity through the maintenance of higher pH conditions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cancer cells compete with immune cells for glucose uptake (by SLC2A1/GLUT1), produce lactic acid (by LDHA), and generate an acidic extracellular milieu (through the activity of CA9), all of which are immunosuppressive.
“Cancer cells compete with immune cells for glucose uptake (by SLC2A1/GLUT1), produce lactic acid (by LDHA), and generate an acidic extracellular milieu (through the activity of CA9), all of which are immunosuppressive (77–86).”
From HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy (2022) · cites this paper as [85]
The Introduction (page not provided) says tumor cells release lactic acid that creates an acidic microenvironment, and the paper reports that low pH inhibits cytotoxic T-cell function. It does not support the claimed competition with immune cells for glucose or identify SLC2A1/GLUT1, LDHA, or CA9 as the mechanisms involved. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · see citing works
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis
Karhausen, J., Furuta, G. T., Tomaszewski, J. E., Johnson, R. S., Colgan, S. P., & Haase, V. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421086 · Cited by 655 · see citing works
Hypoxia inducible factor 1α regulates T cell receptor signal transduction
Neumann, A. K., Yang, J., Biju, M. P., Joseph, S. K., Johnson, R. S., Haase, V. H., Freedman, B. D., & Turka, L. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506070102 · Cited by 120 · see citing works
Current Insights into the role of HIF-1 in cutaneous wound healing
Andrikopoulou, E., Zhang, X., Sebastian, R., Marti, G., Liu, L., M. Milner, S., & W. Harmon, J. (2011) · Current Molecular Medicine · doi:10.2174/156652411795243414 · Cited by 77 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- K. Parmar, P. Mauch, J.A. Vergilio, R. Sackstein, J.D. Down, Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 5431-5436.
- H. Takahashi, J. Cohen, A. Hosmalin, K.B. Cease, R. Houghten, J.L. Cornette, et al., An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes, Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 3105-3109.
- P. Vaupel, F. Kallinowski, P. Okunieff, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review, Cancer Res. 49 (1989) 6449-6465.
- G.L. Wang, B.H. Jiang, E.A. Rue, G.L. Semenza, Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc. Natl. Acad. Sci. U. S. A 92 (1995) 5510-5514.
- K.R. Atkuri, L.A. Herzenberg, Culturing at atmospheric oxygen levels impacts lymphocyte function, Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 3756-3759.
- K.R. Atkuri, L.A. Herzenberg, A.K. Niemi, T. Cowan, Importance of culturing primary lymphocytes at physiological oxygen levels, Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4547-4552.
Cited by
Sorted by citations
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Schaaf, M. B., Garg, A. D., & Agostinis, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0061-0 · Cited by 629 · see citing works
Salman, S., Meyers, D. J., Wicks, E. E., Lee, S. N., Datan, E., Thomas, A. M., Anders, N. M., Hwang, Y., Lyu, Y., Yang, Y., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci156774 · Cited by 111 · see citing works
Cancer-associated adipocytes as immunomodulators in cancer
Wu, Q., Li, B., Li, J., Sun, S., Yuan, J., & Sun, S. (2021) · Biomarker Research · doi:10.1186/s40364-020-00257-6 · Cited by 105 · see citing works
Immunotherapies for pediatric cancer: current landscape and future perspectives
Hutzen, B., Paudel, S. N., Naeimi Kararoudi, M., Cassady, K. A., Lee, D. A., & Cripe, T. P. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09819-z · Cited by 44 · see citing works
Murthy, A., Gerber, S. A., Koch, C. J., & Lord, E. M. (2019) · ImmunoHorizons · doi:10.4049/immunohorizons.1900017 · Cited by 36 · see citing works
Multifaceted Interplay between Hormones, Growth Factors and Hypoxia in the Tumor Microenvironment
Lappano, R., Todd, L. A., Stanic, M., Cai, Q., Maggiolini, M., Marincola, F., & Pietrobon, V. (2022) · Cancers · doi:10.3390/cancers14030539 · Cited by 32 · see citing works
- Authors
- Nakagawa, Y., Negishi, Y., Shimizu, M., Takahashi, M., Ichikawa, M., & Takahashi, H.
- Affiliations
- Nippon Medical School (JP)
- Corresponding author
- Nakagawa, Yohko
- Venue
- Immunology Letters
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 167
- Issue
- 2
- Pages
- 72-86
- ISSN
- 0165-2478 (ISSN-L)
- OpenAlex
- W1006554241
- Cited by
- 149
- References
- 4
- Citations by year
- 2026: 8 · 2025: 15 · 2024: 16 · 2023: 9 · 2022: 26 · 2021: 17 · 2020: 20 · 2019: 17 · 2018: 12 · 2017: 6 · 2016: 2 · 2015: 1
- FWCI
- 3.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Immunology Letters (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Science, Sport, and Culture
- Ministry of Health and Labor and Welfare, Japan
- Japanese Health Sciences Foundation
- Promotion and Mutual Aid Corporation for Private Schools of Japan
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- cytotoxic T lymphocytes, extracellular pH, hypoxia, tumor microenvironment, CTL cytotoxicity, CTL induction, antigen-specific T cells, tumor immunosuppression, tumor growth control
- MeSH terms
- Acidosis, Animals, Hypoxia, Antigens, Cell Line, Cytotoxicity, Immunologic, Extracellular Space, Female, Hydrogen-Ion Concentration, Mice, Transgenic, Ovalbumin, Oxygen Consumption, T-Lymphocytes, Cytotoxic, Epitopes, T-Lymphocyte, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review